Finnegan Beats Humira IP Licensing Claims for AbbVie

A U.K. arthritis research trust overreached by demanding more patent royalties from drugmaker and longtime licensee AbbVie, an appeals court ruled on Thursday.

Sign up for a free Law.com trial now!

Law.com's Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on Law.com
  • The free Law.com InPractice digital newsletter
  • Personalized legal news on the Law.com mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Law.com Newswire digital newsletter.